BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31036418)

  • 1. The molecular differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma: A bioinformatics study.
    Wang J; Xi X; Shang W; Acharya A; Li S; Savkovic V; Li H; Haak R; Schmidt J; Liu X; Deng Y; Pan H; Obradovic D; Schmalz G; Ziebolz D; Hu X
    Am J Otolaryngol; 2019; 40(4):547-554. PubMed ID: 31036418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.
    Miller DL; Davis JW; Taylor KH; Johnson J; Shi Z; Williams R; Atasoy U; Lewis JS; Stack MS
    Am J Pathol; 2015 Mar; 185(3):679-92. PubMed ID: 25572154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
    Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
    Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
    Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer.
    House R; Majumder M; Janakiraman H; Ogretmen B; Kato M; Erkul E; Hill E; Atkinson C; Barth J; Day TA; Palanisamy V
    PLoS One; 2018; 13(10):e0205077. PubMed ID: 30289952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
    Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
    J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.
    De Ruyck K; Duprez F; Ferdinande L; Mbah C; Rios-Velazquez E; Hoebers F; Praet M; Deron P; Bonte K; Speel EJ; Libbrecht L; De Neve W; Lambin P; Thierens H
    Cancer Epidemiol; 2014 Oct; 38(5):591-8. PubMed ID: 25127693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.
    Chen B; Hua Z; Qin X; Li Z
    Neurochem Res; 2021 Feb; 46(2):197-212. PubMed ID: 33104965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer.
    Božinović K; Sabol I; Dediol E; Milutin Gašperov N; Manojlović S; Vojtechova Z; Tachezy R; Grce M
    Sci Rep; 2019 Feb; 9(1):2306. PubMed ID: 30783190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.
    Yuan Y; Sturgis EM; Zhu L; Lu M; Li Y; Wei Q; Li G
    Mol Carcinog; 2017 Mar; 56(3):1100-1106. PubMed ID: 27677255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
    Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A
    Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
    Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
    Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b.
    Inoue H; Hirasaki M; Kogashiwa Y; Kuba K; Ebihara Y; Nakahira M; Sakai A; Okuda A; Sugasawa M
    Acta Otolaryngol; 2021 Jun; 141(6):640-645. PubMed ID: 33794725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI.
    Quabius ES; Merz I; Görögh T; Hedderich J; Haag J; Röcken C; Ambrosch P; Hoffmann M
    Papillomavirus Res; 2017 Dec; 4():26-34. PubMed ID: 29179866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer.
    Idris S; Lindsay C; Kostiuk M; Andrews C; Côté DW; O'Connell DA; Harris J; Seikaly H; Biron VL
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):54. PubMed ID: 27793210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared genetic and epigenetic mechanisms between chronic periodontitis and oral squamous cell carcinoma.
    Li S; Liu X; Zhou Y; Acharya A; Savkovic V; Xu C; Wu N; Deng Y; Hu X; Li H; Haak R; Schmidt J; Shang W; Pan H; Shang R; Yu Y; Ziebolz D; Schmalz G
    Oral Oncol; 2018 Nov; 86():216-224. PubMed ID: 30409304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.
    Boscolo-Rizzo P; Pawlita M; Holzinger D
    Cancer Treat Rev; 2016 Jan; 42():24-9. PubMed ID: 26547133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.